Chlorhexidine Vaginal Preparation for Reduction of Post-cesarean Endometritis and Sepsis
The Impact of Chlorhexidine Preoperative Vaginal Preparation in Reducing the Post-cesarean Endometritis and Sepsis for Cases in Labor. A Randomized Controlled Trial
1 other identifier
interventional
840
1 country
1
Brief Summary
The study aims to assess the beneficial value of vaginal preparation with chlorhexidine gluconate 0.05% before cesarean delivery of cases in labor in reduction of postoperative endometritis, fever and wound complications compared to no preparation or using saline only.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_1
Started May 2020
Typical duration for phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 9, 2020
CompletedFirst Posted
Study publicly available on registry
May 13, 2020
CompletedStudy Start
First participant enrolled
May 15, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 10, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
August 30, 2022
CompletedSeptember 23, 2022
September 1, 2022
1.8 years
May 9, 2020
September 22, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
post-cesarean endometritis
uterine fundal tenderness on bimanual examination ( physical examination: suprapubic tenderness, pain elicited by cervical motion, tenderness in parametrium, all during bimanual examination) + with fever (An oral temperature of 38°C or higher within the first 10 days postpartum or 38.7°C within the first 24 hours postpartum) ± purulent lochia requiring antibiotic therapy ( initial antibiotic will be started then waiting for proper therapy according to culture and sensitivity
First 10 days post-cesarean
Postoperative wound infection
erythema, warmth, tenderness, purulent drainage from the incision site, with or without fever, requiring antibiotic therapy.
First month after cesarean
Secondary Outcomes (4)
Significant leukocytosis
First 10 days postcesarean
Chlorhexidine adverse drug reaction
First 10 days
incidence of hospital readmission
One month
length of hospital stay
One month
Study Arms (2)
Chlorhexidine vaginal prep.arm
EXPERIMENTALWomen in labor who will receive vaginal cleaning immediately before cesarean section using 50 ml of chlorhexidine gluconate 0.05% solution and standard abdominal scrub with chlorhexidine gluconate 4%. This concentration is indicated within the British National Formulary for swabbing in obstetrics. A swab soaked in the antiseptic will be used to clean the vagina for 30 seconds prior to CS at the time of urinary catheter insertion by long forceps. After the CS procedure, the vagina is always cleaned of excess blood as with a dry swab.
No vaginal antiseptic arm
NO INTERVENTIONWomen in labor who will receive abdominal scrub with chlorhexidine gluconate 4% only. Vaginal preparation is not including antiseptic or using normal saline only.
Interventions
preoperative vaginal preparation
Eligibility Criteria
You may qualify if:
- Gestational age ≥28 weeks.
- Cases had cesarean section after start of labor.
You may not qualify if:
- Women with known allergy to chlorhexidine gluconate or any of its ingredients.
- Women with diagnosed group B streptococcus (GBS) colonization.
- Women with active infection during the procedure.
- Women did not receive the standard preoperative antibiotic prophylaxis.
- Women with diagnosis of chorioamnionitis.
- Prolonged rupture of membranes \>7 days
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Armed Forces Hospitals Southern Region
Khamis Mushait, 62411, Saudi Arabia
Related Publications (3)
Betran AP, Ye J, Moller AB, Zhang J, Gulmezoglu AM, Torloni MR. The Increasing Trend in Caesarean Section Rates: Global, Regional and National Estimates: 1990-2014. PLoS One. 2016 Feb 5;11(2):e0148343. doi: 10.1371/journal.pone.0148343. eCollection 2016.
PMID: 26849801BACKGROUNDZuarez-Easton S, Zafran N, Garmi G, Salim R. Postcesarean wound infection: prevalence, impact, prevention, and management challenges. Int J Womens Health. 2017 Feb 17;9:81-88. doi: 10.2147/IJWH.S98876. eCollection 2017.
PMID: 28255256BACKGROUNDHaas DM, Morgan S, Contreras K, Enders S. Vaginal preparation with antiseptic solution before cesarean section for preventing postoperative infections. Cochrane Database Syst Rev. 2018 Jul 17;7(7):CD007892. doi: 10.1002/14651858.CD007892.pub6.
PMID: 30016540BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ahmed Shafiek
Armed forces hospitals Southern Region KSA
- PRINCIPAL INVESTIGATOR
Hytham Atia
Armed Forces Hospitals Southern Region
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor Obstetrics & Gynecology
Study Record Dates
First Submitted
May 9, 2020
First Posted
May 13, 2020
Study Start
May 15, 2020
Primary Completion
March 10, 2022
Study Completion
August 30, 2022
Last Updated
September 23, 2022
Record last verified: 2022-09
Data Sharing
- IPD Sharing
- Will not share